Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
暂无分享,去创建一个
Marc Ladanyi | Marc K Halushka | Constance Griffin | Pedram Argani | Saraswati Sukumar | M. Ladanyi | M. Fackler | P. Argani | S. Sukumar | M. Halushka | J. Hicks | A. D. De Marzo | N. Davidson | C. Griffin | D. Chitale | D. Molavi | M. Taylor | J. Fetting | Nancy E Davidson | W. Teo | Jessica L Hicks | Angelo M De Marzo | Julie M Wu | Mary Jo Fackler | Diana W Molavi | M Evangeline Taylor | Wei Wen Teo | John Fetting | Dhananjay Chitale | Julie M. Wu
[1] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[2] W. Gradishar. Estrogen Receptor-Positive, Progesterone Receptor-Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance , 2006 .
[3] Zhe Zhang,et al. Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid , 2006, Clinical Cancer Research.
[4] M. Clarke,et al. Stem Cells and Cancer: Two Faces of Eve , 2006, Cell.
[5] Mary E. Choi,et al. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. , 2006, Cancer research.
[6] R. Schiff,et al. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators , 2005, Cancer Chemotherapy and Pharmacology.
[7] Josephine C. Adams,et al. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? , 2005, The international journal of biochemistry & cell biology.
[8] C. Horak,et al. Metastasis gets site specific. , 2005, Cancer cell.
[9] W. Gerald,et al. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations , 2005, Modern Pathology.
[10] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[11] G. Dontu,et al. Mammary stem cells, self-renewal pathways, and carcinogenesis , 2005, Breast Cancer Research.
[12] Adrian V. Lee,et al. Insights into the role of progesterone receptors in breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] W. Gerald,et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.
[14] Joon-Oh Park,et al. Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study , 2005, Cancer Chemotherapy and Pharmacology.
[15] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[16] Pedram Argani,et al. Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer , 2004, Cancer Research.
[17] Ira Pastan,et al. Mesothelin: a new target for immunotherapy. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] Kornelia Polyak,et al. Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung , 2004, Clinical Cancer Research.
[19] M. Fackler,et al. DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.
[20] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Dowsett,et al. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[23] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[25] Martin Widschwendter,et al. DNA methylation and breast carcinogenesis , 2002, Oncogene.
[26] J. Reis-Filho,et al. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. , 2002, Journal of clinical pathology.
[27] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[28] J. Cameron,et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[31] J. Herman,et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. , 2000, Cancer research.
[32] E. Rimm,et al. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma , 1999, Cancer.
[33] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .